Table 2 Mean dose of FLV.
From: Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
Time | FLV (n) | FLV+TJ-43 (n) | |
|---|---|---|---|
1st week | 48.9 ± 5.1 (25) | 48.0 ± 6.9 (25) | n.s. |
2nd week | 85.3 ± 22.6 (19) | 92.1 ± 18.7 (19) | n.s. |
4th week | 125.0 ± 35.0 (13) | 134.2 ± 33.5 (19) | n.s. |
8th week | 129.2 ± 32.5 (13) | 136.1 ± 33.5 (19) | n.s. |